Skip to main content
SpringerLink
Log in

Pharmacological effects of naltrexone and intravenous alcohol on craving for cigarettes among light smokers: a pilot study

  • Original Investigation
  • Published:
Psychopharmacology Aims and scope Submit manuscript

Abstract

Rationale

Although naltrexone has been widely researched in the context of drinking and smoking behaviors, with each substance studied separately, little is known about the effects of naltrexone on craving for cigarettes during alcohol intoxication.

Objectives

The present study used a within-subjects double-blind placebo-controlled design to (1) examine the effects of alcohol, administered intravenously, on craving for cigarettes; (2) test the effects of naltrexone on cigarette craving during alcohol intoxication; and (3) examine the relationship between craving for alcohol and cigarettes across rising breath alcohol concentrations (BrACs).

Materials and methods

Heavy drinking light smokers completed two counterbalanced intravenous alcohol challenge sessions, one after taking naltrexone (50 mg) for 3 days and one after taking a placebo for 3 days. During each session, participants reported on their craving for alcohol and cigarettes.

Results

Analyses revealed a significant positive effect of BrAC on urge to smoke as well as a BrAC × Medication interaction. Specifically, the linear relationship between BrAC and urge to smoke was significantly weaker in the naltrexone condition, as compared to placebo. There was also a positive association between urge to drink and urge to smoke, and this relationship was moderated by BrAC.

Conclusions

These findings demonstrate that the pharmacological effects of alcohol alone induce craving for cigarettes and that naltrexone blunts the progression of craving for cigarettes during alcohol intoxication. These results highlight the potential clinical utility of naltrexone for heavy drinkers trying to quit smoking.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2

Similar content being viewed by others

References

  • Allen JP, Litten RZ, Fertig JB, Babor T (1997) A review of research on the Alcohol Use Disorders Identification Test (AUDIT). Alcohol Clin Exp Res 21:613–619

    PubMed  CAS  Google Scholar 

  • Anton RF, Moak DH, Waid LR, Latham PK, Malcolm RJ, Dias JK (1999) Naltrexone and cognitive behavioral therapy for the treatment of outpatient alcoholics: results of a placebo-controlled trial. Am J Psychiatry 156:1758–1764

    PubMed  CAS  Google Scholar 

  • Anton RF, Drobes DJ, Voronin K, Durazo-Avizu R, Moak D (2004) Naltrexone effects on alcohol consumption in a clinical laboratory paradigm: temporal effects of drinking. Psychopharmacology 173:32–40

    Article  PubMed  CAS  Google Scholar 

  • Anton RF, O’Malley SS, Ciraulo DA, Cisler RA, Couper D, Donavan DM et al (2006) Combined pharmacotherapies and behavioral interventions for alcohol dependence, the COMBINE study: a randomized controlled trial. JAMA 295:2003–2017

    Article  PubMed  CAS  Google Scholar 

  • Balldin J, Berglund M, Borg S, Mansson M, Bendtsen P, Franck J et al (2003) A 6-month controlled naltrexone study: Combined effect with cognitive behavioral therapy in outpatient treatment of alcohol dependence. Alcohol Clin Exp Res 27:1142–1149

    Article  PubMed  CAS  Google Scholar 

  • Barrett SP, Tichauer M, Leyton M, Pihl RO (2006) Nicotine increases alcohol self-administration in non-dependent male smokers. Drug Alcohol Depend 81:197–204

    Article  PubMed  CAS  Google Scholar 

  • Bjartveit K, Tverdal A (2005) Health consequences of smoking 1–4 cigarettes per day. Tob Control 14:315–320

    Article  PubMed  CAS  Google Scholar 

  • Burton SM, Tiffany ST (1997) The effect of alcohol consumption on craving to smoke. Addiction 92:15–26

    Article  PubMed  CAS  Google Scholar 

  • Byars JA, Frost-Pineda K, Jacobs WS (2005) Naltrexone augments the effects of nicotine replacement therapy in female smokers. J Addict Dis 24:49–60

    Article  PubMed  Google Scholar 

  • Covey LS, Glassman AH, Stetner F (1999) Naltrexone effects on short-term and long-term smoking cessation. J Addict Dis 18:31–40

    Article  PubMed  CAS  Google Scholar 

  • Davidson RJ (2003) Affective neuroscience and psychophysiology: toward a synthesis. Psychophysiology 44:655–665

    Article  Google Scholar 

  • Davidson D, Swift R, Fitz E (1996) Naltrexone increase the latency to drink alcohol in social drinkers. Alcohol Clin Exp Res 20:732–739

    Article  PubMed  CAS  Google Scholar 

  • Dawson DA (2000) Drinking as a risk factor for sustained smoking. Drug Alcohol Depend 59:235–249

    Article  PubMed  CAS  Google Scholar 

  • Del Boca FK, Kranzler HR, Brown J, Korner PF (1996) Assessment of medication compliance in alcoholics through UV light detection of a riboflavin tracer. Alcohol Clin Exp Res 20:1412–1417

    Article  PubMed  Google Scholar 

  • Drobes DJ, Anton RF, Thomas SE, Vornin K (2004) Effects of naltrexone and nalmefene on subjective response to alcohol among non-treatment seeking alcoholics and social drinkers. Alcohol Clin Exp Res 28:1362–1370

    Article  PubMed  CAS  Google Scholar 

  • Epstein AM, King AC (2004) Naltrexone attenuates acute cigarette smoking behavior. Pharmacol Biochem Behav 77:29–37

    Article  PubMed  CAS  Google Scholar 

  • Epstein AM, Sher TG, Young MA, King AC (2007) Tobacco chippers show robust increases in smoking urge after alcohol consumption. Psychopharmacology 190(3): 321–329

    Article  PubMed  CAS  Google Scholar 

  • Glautier S, Clements K, White JA, Taylor C, Stolerman IP (1996) Alcohol and the reward value of cigarette smoking. Behav Pharmacol 7:144–154

    Article  PubMed  CAS  Google Scholar 

  • Guardia J, Caso C, Arias F, Gual A, Sanahuja J, Ramirez M et al (2002) A double-blind, placebo-controlled study of naltrexone in the treatment of alcohol-dependence disorder: results from a multicenter clinical trial. Alcohol Clin Exp Res 26:1381–1387

    PubMed  CAS  Google Scholar 

  • Hutchison KE, Monti PM, Rohsenow DJ, Swift R, Colby SM, Gnys M, Niaura RS, Sirota AD (1999) Effects of naltrexone with nicotine replacement on smoking cue-reactivity: preliminary results. Psychopharmacology 142:139–143

    Article  PubMed  CAS  Google Scholar 

  • Kahler CW, Resendes A, Monti PM, Ramsey SE, Abrams DA, Brown RA (2005) Alcohol use and smoking outcomes among heavy drinkers in smoking cessation treatment. In: Society for Research on Nicotine and Tobacco Annual Meeting, Prague, Czech Republic

  • King AC, Epstein AM (2005) Alcohol dose-dependent increases in smoking urge in light smokers. Alcohol Clin Exp Res 29:547–552

    Article  PubMed  Google Scholar 

  • King AC, Meyer PJ (2000) Naltrexone alteration of acute smoking response in nicotine-dependent subjects. Pharmacol Biochem Behav 66:563–572

    Article  PubMed  CAS  Google Scholar 

  • King A, de Wit H, Riley RC, Cao D, Niaura R, Hatsukami D (2006) Efficacy of naltrexone in smoking cessation: a preliminary study and an examination of sex differences. Nicotine Tob Res 8:671–682

    Article  PubMed  CAS  Google Scholar 

  • Kouri EM, McCarthy EM, Faust AH, Lukas SE (2004) Pretreatment with transdermal nicotine enhances some of ethanol's acute effects in men. Drug Alcohol Depend 75(1):55–65

    Article  PubMed  CAS  Google Scholar 

  • Lee YS, Joe KH, Sohn IK, Na C, Kee BS, Chae SL (2005) Changes of smoking behavior and serum adrenocorticotropic hormone, cortisol, prolactin, and endogenous opioids levels in nicotine dependence after naltrexone treatment. Prog Neuropsychopharmacol Biol Psychiatry 29:639–647

    Article  PubMed  CAS  Google Scholar 

  • Li T, Yin S, Crabb DW, O’Connor S, Ramchandani VA (2001) Genetic and environmental influences on alcohol metabolism in humans. Alcohol Clin Exp Res 25:136–144

    Article  PubMed  CAS  Google Scholar 

  • Littleton J, Zieglgansberger W (2003) Pharmacological mechanisms of naltrexone and acamprosate in the prevention of relapse in alcohol dependence. Am J Addict 12:3–11

    Article  Google Scholar 

  • McCaul ME, Wand GS, Stauffer R, Lee SM, Rohde CA (2001) Naltrexone dampens ethanol-induced cardiovascular and hypothalamic–pituitary–adrenal axis activation. Neuropsychopharmacology 25:537–547

    Article  PubMed  CAS  Google Scholar 

  • Mello NK, Mendelson JH, Sellers ML, Kuehnle JC (1980) Effect of alcohol and marijuana on tobacco smoking. Clin Pharmacol Ther 27:202–209

    Article  PubMed  CAS  Google Scholar 

  • Mitchell SH, de Wit H, Zacny JP (1995) Effects of varying ethanol dose on cigarette consumption in healthy normal volunteers. Behav Pharmacol 6:359–365

    PubMed  CAS  Google Scholar 

  • Monti PM, Rohsenow DJ, Hutchison KE, Swift RM, Mueller TI, Colby SM et al (1999) Naltrexone’s effect on cue-elicited craving among alcoholics in treatment. Alcohol Clin Exp Res 23:1386–1394

    PubMed  CAS  Google Scholar 

  • Monti PM, Rohsenow DJ, Swift RM, Gulliver SB, Colby SM, Mueller TI et al. (2001) Naltrexone and cue exposure with coping and communication skills training for alcoholics: Treatment process and 1-year outcomes. Alcohol Clin Exp Res 25:1634–1647

    Article  PubMed  CAS  Google Scholar 

  • Ockene JK, Adams A (1995) Screening and intervention for smoking and alcohol use in primary care settings: similarities, differences, gaps, and challenges. In: Fertig JB, Allen JP (eds) Alcohol and tobacco: from basic science to clinical practice. National Institutes of Health, Bethesda, MD, pp 281–294

    Google Scholar 

  • O’Connor S, Morzorati S, Christian J, Li T (1998) Clamping breath alcohol concentration reduces experimental variance: Application to the study of acute tolerance to alcohol and alcohol elimination rate. Alcohol Clin Exp Res 22:202–210

    PubMed  CAS  Google Scholar 

  • O’Malley SS, Jaffe AJ, Change G, Schottenfeld RS, Meyer RE, Rounsaville B (1992) Naltrexone and coping skills therapy for alcohol dependence: a controlled study. Arch Gen Psychiatry 49:881–887

    PubMed  CAS  Google Scholar 

  • O’Malley SS, Cooney JL, Krishnan-Sarin S, Dubin JA, McKee SA, Cooney NL et al (2006) A controlled trial of naltrexone augmentation of nicotine replacement therapy for smoking cessation. Arch Intern Med 166:667–674

    Article  PubMed  CAS  Google Scholar 

  • Perkins KA, Sexton JE, DiMarco A, Grobe JE, Scierka A, Stiller RL (1995) Subjective and cardiovascular responses to nicotine combined with alcohol in male and female smokers. Psychopharmacology 119:205–212

    Article  PubMed  CAS  Google Scholar 

  • Ramchandani VA, Bolane J, Li TK, O’Connor S (1999) A physiologically-based pharmacokinetic (PBPK) model for alcohol facilitates rapid BrAC clamping. Alcohol Clin Exp Res 23:617–623

    PubMed  CAS  Google Scholar 

  • Ray LA, Hutchison KE (2004) A polymorphism of the mu-opioid receptor gene and sensitivity to the effects of alcohol in humans. Alcohol Clin Exp Res 28:1789–1795

    Article  PubMed  CAS  Google Scholar 

  • Ray LA, Hutchison KE (2007) A double-blind placebo-controlled study of the effects of naltrexone on alcohol sensitivity and genetic moderators of medication response. Arch Gen Psychiatry, in press

  • Ray LA, McGeary J, Marshall E, Hutchison KE (2006) Risk factors for alcohol misuse: integrating heart rate response to alcohol, alcohol sensitivity, and personality factors. Addict Behav 31:1959–1973

    Article  PubMed  Google Scholar 

  • Ray LA, Meskew-Stacer S, Hutchison KE (2007) The relationship between prospective self-rating of alcohol sensitivity and craving and experimental results from two alcohol challenge studies. J Stud Alcohol Drugs 68(3)379–384

    Google Scholar 

  • Rimm EB, Chan J, Stampfer MJ, Colditz GA, Willett WC (1995) Prospective study of cigarette smoking, alcohol use, and the risk of diabetes in men. Br Med J 310:555–559

    CAS  Google Scholar 

  • Rohsenow DJ, Monti PM, Colby SM, Gulliver SB, Swift RM, Abrams DB (2003) Naltrexone treatment for alcoholics: effect on cigarette smoking rates. Nicotine Tob Res 5:231–236

    Article  PubMed  CAS  Google Scholar 

  • Rohsenow DJ, Monti PM, Hutchison KE, Swift RM, MacKinnon SV, Sirota AD et al (2007) High dose transdermal nicotine and naltrexone: Effects on nicotine withdrawal, urges, smoking, and effects of smoking. Exp Clin Psychopharmacol 15(1):81–92

    Article  PubMed  CAS  Google Scholar 

  • Rose JE, Brauer LH, Behm FM, Cramblett M, Calkins K, Lawhon D (2002) Potentiation of nicotine reward by alcohol. Alcohol Clin Exp Res 6:930–1931

    Google Scholar 

  • Rose JE, Brauer LH, Behm FM, Cramblett M, Calkins K, Lawhon D (2004) Psychopharmacological interactions between nicotine and ethanol. Nicotine Tob Res 6:133–144

    Article  PubMed  CAS  Google Scholar 

  • Rubio G, Manzanares J, Lopez-Munoz F, Alamo C, Ponce G, Jimenez-Arriero, MA, Palomo T (2002) Naltrexone improves outcome of a controlled drinking program. J Subst Abuse Treat 23:361–366

    Article  PubMed  Google Scholar 

  • Rukstalis M, Jepson C, Strasser A, Lynch KG, Perkins K, Patterson F et al (2005) Naltrexone reduces the relative reinforcing value of nicotine in a cigarette smoking choice paradigm. Psychopharmacology 180:41–48

    Article  PubMed  CAS  Google Scholar 

  • SAS Institute 2003. The SAS system for windows (version 8.2) SAS Institute, Cary, NC

    Google Scholar 

  • Sayette MA, Martin CS, Wertz JM, Perrott MA, Peters AR (2005) The effects of alcohol on cigarette craving in heavy smokers and tobacco chippers. Psychol Addict Behav 19:263–270

    Article  PubMed  Google Scholar 

  • Schoenborn CA, Adams PF, Barnes PM, Vickerie JL, Schiller JS (2004) Health behaviors of adults: United States, 1999–2001. Vital Health Stat 10(219):1–79

    Google Scholar 

  • Shiffman S, Fischer LA, Paty JA, Gnys M, Hickcox M, Kassel JD (1994) Drinking and smoking: a field study of their association. Annals Behav Med 16:203–209

    Google Scholar 

  • Strizke WGK, Breiner MJ, Curtin JJ, Lang AR (2004) Assessment of substance cue reactivity: advances in reliability, specificity, and validity. Psychol Addict Behav 18:148–159

    Article  Google Scholar 

  • Sutherland G, Stapleton JA, Russell MA, Feyerabend C (1995) Naltrexone, smoking behaviour and cigarette withdrawal. Psychopharmacology 120:418–425

    Article  PubMed  CAS  Google Scholar 

  • Swift RM, Whelihan W, Kusnetsov O, Buongiorno G, Hsuing H (1994) Naltrexone-induced alterations in human ethanol intoxication. Am J Psychiatry 151:1463–1467

    PubMed  CAS  Google Scholar 

  • Volpicelli JR, Alterman AI, Hayashida M, O’Brien CP (1992) Naltrexone in the treatment of alcohol dependence. Arch Gen Psychiatry 49:876–880

    PubMed  CAS  Google Scholar 

  • Wewers ME, Dhatt R, Tejwani GA (1998) Naltrexone administration affects ad libitum smoking behavior. Psychopharmacology 140:185–190

    Article  PubMed  CAS  Google Scholar 

  • White HR, Labouvie EW (1989) Towards the assessment of adolescent problem drinking. J Stud Alcohol 50:30–37

    PubMed  CAS  Google Scholar 

Download references

Acknowledgements

The authors would like to acknowledge the assistance of Amy Audette, Stephanie Dicristoforo, Keira Odell, and Jenifer Bishop on data collection for this project. The authors also wish to thank the staff at the General Clinical Research Center at the University of Colorado, at Boulder.

The authors would like to state that the study described in this manuscript complied with the current laws of the USA.

Grant support: This research was supported by grants from the National Institute on Alcoholism and Alcohol Abuse to L. A. R. (AA14847) and K. E. H. (AA012238) and by a grant from the General Clinical Research Center Program of the National Center for Research Resources, National Institutes of Health (M01-RR00051).

Author information

Authors and Affiliations

  1. Department of Psychology, University of Colorado at Boulder, Muenzinger Psychology Building, 345 UCB, Boulder, CO, 80309-0345, USA

    Lara A. Ray & Kent E. Hutchison

  2. Center for Alcohol and Addiction Studies, Brown University, Providence, RI, USA

    Lara A. Ray, Robert Miranda Jr., Christopher W. Kahler, Adam M. Leventhal, Peter M. Monti & Robert Swift

  3. Department of Veterans Affairs Medical Center, Providence, RI, USA

    Peter M. Monti & Robert Swift

Authors
  1. Lara A. Ray
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Robert Miranda Jr.
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Christopher W. Kahler
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Adam M. Leventhal
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Peter M. Monti
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Robert Swift
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Kent E. Hutchison
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Lara A. Ray.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Ray, L.A., Miranda, R., Kahler, C.W. et al. Pharmacological effects of naltrexone and intravenous alcohol on craving for cigarettes among light smokers: a pilot study. Psychopharmacology 193, 449–456 (2007). https://doi.org/10.1007/s00213-007-0794-z

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00213-007-0794-z

Keywords

Search

Navigation